<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02294669</url>
  </required_header>
  <id_info>
    <org_study_id>Turris</org_study_id>
    <nct_id>NCT02294669</nct_id>
  </id_info>
  <brief_title>A Feasibility Study to Evaluate the TURRIS Facet Fusion System in Lumbar Spinal Surgery</brief_title>
  <official_title>A Feasibility Study to Evaluate the TURRIS Facet Fusion System as an Adjuvant to Unilateral Pedicle Screw Fixation in Lumbar Spinal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SpineWelding AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ISS integrated Scientific Services AG</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>SpineWelding AG</source>
  <brief_summary>
    <textblock>
      This is a prospective, exploratory study to verify intra-operative handling and safety and to&#xD;
      collect preliminary short-term safety and efficacy data of the Turris® Facet Fuser, a small&#xD;
      bioresorbable device for the immediate immobilization of the facet joint.&#xD;
&#xD;
      Patients eligible for study enrollment will present with degenerative lumbar spinal diseases&#xD;
      involving the L4/L5 segment and requiring spinal fusion.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Turris® Facet Fuser is an investigational resorbable device intended to support spinal&#xD;
      segment fusion in individuals suffering from degenerative lumbar spinal diseases. The device&#xD;
      is directly inserted in the facet joint of the affected segment using the BoneWelding®&#xD;
      technology, a soft tissue sparing, ultrasound based insertion method which confers immediate&#xD;
      stability to the implant.&#xD;
&#xD;
      Aim of this prospective, exploratory study is to verify intra-operative handling and safety&#xD;
      of the Turris® Facet Fusion System and to collect preliminary short-term safety and efficacy&#xD;
      data on this innovative implant by observing the healing process over a period of one year.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2015</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The number, severity and causality of intra-operative and post-operative complications</measure>
    <time_frame>1 year</time_frame>
    <description>Patients will be observed during hospitalization, at 6 weeks, 3 months, 6 months and 12 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fusion of the L4/L5 Segment</measure>
    <time_frame>within 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Spine Tango Oswestry score</measure>
    <time_frame>Baseline, 3 months, 6 months and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Spine Tango COMI score</measure>
    <time_frame>Baseline, 3 months, 6 months and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Spine Tango VAS score for back- and leg-pain</measure>
    <time_frame>Baseline, 3 months, 6 months and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative radiation exposure</measure>
    <time_frame>intra-operative</time_frame>
    <description>Radiation exposure time during the insertion process of the pedicle screw system and the Turris Facet Fusion will be recorded separately</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Spinal Disease</condition>
  <arm_group>
    <arm_group_label>Turris Facet Fuser</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Turris Facet Fuser</intervention_name>
    <description>Study participants will have a Turris Facet Fuser inserted into the contralateral facet joint, instead of a state of the art contralateral pedicle screw system.</description>
    <arm_group_label>Turris Facet Fuser</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  one-level fusion at L4/L5 with dorsal instrumentation and, if required, with&#xD;
             monolateral decompression and/or intervertebral disc removal and implantation of an&#xD;
             intervertebral implant&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Patient&#xD;
&#xD;
          -  had previous surgical stabilizations at the involved or adjacent levels&#xD;
&#xD;
          -  has lytic spondylolisthesis&#xD;
&#xD;
          -  has degenerative spondylolisthesis grade II or higher&#xD;
&#xD;
          -  has radiographic signs of significant instability and/or hypermobility of the segment&#xD;
             (&gt;3mm translation, &gt;11° rotation difference from adjacent level)&#xD;
&#xD;
          -  has scoliosis &gt; 10° at the involved segment&#xD;
&#xD;
          -  has osteoporosis to a degree that spinal instrumentation would be contraindicated.&#xD;
&#xD;
          -  has presence of active malignancy.&#xD;
&#xD;
          -  has overt or active infection, either local or systemic&#xD;
&#xD;
          -  is less than 18 years old&#xD;
&#xD;
          -  is pregnant or plan a pregnancy during the study duration&#xD;
&#xD;
          -  has a BMI &gt; 35&#xD;
&#xD;
          -  has a progressive neuromuscular disease&#xD;
&#xD;
          -  has a condition which requires postoperative medications that may interfere with bone&#xD;
             metabolism&#xD;
&#xD;
          -  has a history of autoimmune disease&#xD;
&#xD;
          -  has a history of endocrine or metabolic disorders known to affect osteogenesis&#xD;
&#xD;
          -  is mentally ill or incompetent&#xD;
&#xD;
          -  is an alcohol and/or drug abuser&#xD;
&#xD;
          -  is not available for follow up visits&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ulrich Berlemann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rückenzentrum Oberaargau</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Barbara Froesch, Ph.D.</last_name>
    <phone>+41 44 204 61 25</phone>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Joerg Mayer, Ph.D.</last_name>
    <phone>+41 44 204 61 28</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Neuro- und Wirbelsäulenzentrum</name>
      <address>
        <city>Cham</city>
        <state>CH</state>
        <zip>6330</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Urs I. Zuberbühler, MD</last_name>
    </contact>
    <investigator>
      <last_name>Urs I. Zuberbühler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rückenzentrum Oberaargau AG</name>
      <address>
        <city>Langenthal</city>
        <zip>4900</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ulrich Berlemann, MD</last_name>
    </contact>
    <investigator>
      <last_name>Ulrich Berlemann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>November 3, 2014</study_first_submitted>
  <study_first_submitted_qc>November 14, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 19, 2014</study_first_posted>
  <last_update_submitted>October 21, 2020</last_update_submitted>
  <last_update_submitted_qc>October 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

